Urine Output Decreased

Nephrology·MeSH: Oliguria

5 drugs in development·2 companies·1 clinical trial

Drug Pipeline by Phase

Phase 2(1)

Drug	Company
Dabrafenib plus Trametinib	ENANTA PHARMACEUTICALS INC (ENTA)

N/A(2)

Drug	Company
Furosemide	ENANTA PHARMACEUTICALS INC (ENTA)
Furosemide	Crinetics Pharmaceuticals, Inc. (CRNX)

Phase 4(2)

Drug	Company
Albumin infusion	ENANTA PHARMACEUTICALS INC (ENTA)
Furosemide plus albumin	ENANTA PHARMACEUTICALS INC (ENTA)

BioSniper tracks 5 drugs in development for Urine Output Decreased across 2 companies.

There are 1 clinical trial targeting Urine Output Decreased tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.